NYSE : TFX
Teleflex Incorporated — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 139.77 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.92B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.92B |
| Enterprise Value | 8.54B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 14, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.37M |
| Shares Outstanding | 42.37M |
| Shares Change (YoY) | -4.13% |
| Shares Change (QoQ) | -1.35% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 113.78% |
| Float | 42.21M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 15.17 |
| PS Ratio | 2.63 |
| Forward PS | 2.56 |
| PB Ratio | 2.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.11 |
| P/OCF Ratio | 14.69 |
| PEG Ratio | 0.74 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.79 |
| EV / EBITDA | 21.13 |
| EV / EBIT | 43.08 |
| EV / FCF | 26.10 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.60 |
| Quick Ratio | 0.96 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 6.81 |
| Debt / FCF | 8.98 |
| Interest Coverage | 1.74 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -0.70% |
| Return on Assets (ROA) | 1.75% |
| Return on Invested Capital (ROIC) | 3.60% |
| Return on Capital Employed (ROCE) | 3.27% |
| Weighted Average Cost of Capital (WACC) | 6.91% |
| Revenue Per Employee | $145,453 |
| Profits Per Employee | -$66,560 |
| Employee Count | 15,500 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.94 |
Taxes
| Measure | Value |
|---|
| Income Tax | -38.50M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +9.09% |
| 50-Day Moving Average | 131.34 |
| 200-Day Moving Average | 125.16 |
| Relative Strength Index (RSI) | 67.92 |
| Average Volume (20 Days) | 692,748 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.22M |
| Short Previous Month | 4.00M |
| Short % of Shares Out | 9.95% |
| Short % of Float | 9.99% |
| Short Ratio (days to cover) | 4.99 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.25B |
| Gross Profit | 1.24B |
| Operating Income | 198.11M |
| Pretax Income | -63.55M |
| Net Income | -1.03B |
| EBITDA | 403.90M |
| EBIT | 198.11M |
| Loss Per Share | -$23.41 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 323.94M |
| Total Debt | 2.94B |
| Net Cash | -2.61B |
| Net Cash Per Share | -$61.66 |
| Equity (Book Value) | 2.90B |
| Book Value Per Share | 68.55 |
| Working Capital | 1.16B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 403.20M |
| Capital Expenditures | -76.14M |
| Depreciation & Amortization | 205.79M |
| Net Borrowing | 917.38M |
| Free Cash Flow | 327.06M |
| FCF Per Share | $7.72 |
Margins
| Measure | Value |
|---|
| Gross Margin | 55.11% |
| Operating Margin | 8.79% |
| Pretax Margin | -2.82% |
| Profit Margin | -45.76% |
| EBITDA Margin | 17.92% |
| EBIT Margin | 8.79% |
| FCF Margin | 14.51% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.36 |
| Dividend Yield | 0.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 17.62% |
| Buyback Yield | 4.13% |
| Shareholder Yield | 5.10% |
| Earnings Yield | -16.75% |
| FCF Yield | 5.52% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $154.00 |
| Price Target Difference | 10.18% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 7.49% |
| EPS Growth Forecast (3Y) | 20.12% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 17, 1997 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |